Viking Therapeutics (VKTX) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Viking Therapeutics (VKTX) over the last 11 years, with Q3 2025 value amounting to $318000.0.
- Viking Therapeutics' Total Non-Current Liabilities fell 5788.08% to $318000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $318000.0, marking a year-over-year decrease of 5788.08%. This contributed to the annual value of $630000.0 for FY2024, which is 3269.23% down from last year.
- Per Viking Therapeutics' latest filing, its Total Non-Current Liabilities stood at $318000.0 for Q3 2025, which was down 5788.08% from $410000.0 recorded in Q2 2025.
- Viking Therapeutics' 5-year Total Non-Current Liabilities high stood at $1.5 million for Q1 2022, and its period low was $318000.0 during Q3 2025.
- Over the past 4 years, Viking Therapeutics' median Total Non-Current Liabilities value was $936000.0 (recorded in 2023), while the average stood at $931266.7.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 2073.83% in 2023, then tumbled by 5788.08% in 2025.
- Over the past 4 years, Viking Therapeutics' Total Non-Current Liabilities (Quarter) stood at $1.3 million in 2022, then decreased by 25.71% to $936000.0 in 2023, then crashed by 32.69% to $630000.0 in 2024, then plummeted by 49.52% to $318000.0 in 2025.
- Its Total Non-Current Liabilities was $318000.0 in Q3 2025, compared to $410000.0 in Q2 2025 and $502000.0 in Q1 2025.